Introduction to direct oral anticoagulants and rationale for specific reversal agents

Am J Emerg Med. 2016 Nov;34(11S):1-2. doi: 10.1016/j.ajem.2016.09.045. Epub 2016 Sep 28.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Antidotes
  • Arginine / analogs & derivatives
  • Arginine / therapeutic use
  • Factor Xa / therapeutic use
  • Humans
  • Piperazines / therapeutic use
  • Recombinant Proteins / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Anticoagulants
  • Antidotes
  • PRT064445
  • Piperazines
  • Recombinant Proteins
  • Arginine
  • idarucizumab
  • Factor Xa
  • PER977